Suvretta Capital Management as of June 30, 2020
Portfolio Holdings for Suvretta Capital Management
Suvretta Capital Management holds 80 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Adobe Systems Incorporated (ADBE) | 9.1 | $422M | 970k | 435.31 | |
| Amazon (AMZN) | 5.9 | $274M | 99k | 2758.82 | |
| Facebook Cl A (META) | 5.4 | $253M | 1.1M | 227.07 | |
| Charter Communications Inc N Cl A (CHTR) | 3.6 | $166M | 326k | 510.04 | |
| Activision Blizzard | 3.3 | $152M | 2.0M | 75.90 | |
| Union Pacific Corporation (UNP) | 3.2 | $150M | 885k | 169.07 | |
| Fidelity National Information Services (FIS) | 3.2 | $149M | 1.1M | 134.09 | |
| Otis Worldwide Corp (OTIS) | 3.2 | $148M | 2.6M | 56.86 | |
| Iqvia Holdings (IQV) | 2.9 | $134M | 944k | 141.88 | |
| Uber Technologies (UBER) | 2.7 | $124M | 4.0M | 31.08 | |
| Five Below (FIVE) | 2.6 | $119M | 1.1M | 106.91 | |
| Dollar General (DG) | 2.5 | $118M | 617k | 190.51 | |
| Take-Two Interactive Software (TTWO) | 2.4 | $114M | 814k | 139.57 | |
| Canadian Pacific Railway | 2.3 | $108M | 423k | 255.34 | |
| Global Payments (GPN) | 2.3 | $107M | 628k | 169.62 | |
| Royalty Pharma Shs Cl A (RPRX) | 2.2 | $105M | 2.2M | 48.55 | |
| Baxter International (BAX) | 2.2 | $104M | 1.2M | 86.10 | |
| Jacobs Engineering | 2.2 | $103M | 1.2M | 84.80 | |
| UnitedHealth (UNH) | 2.1 | $97M | 328k | 294.95 | |
| Paypal Holdings (PYPL) | 2.0 | $94M | 541k | 174.23 | |
| TJX Companies (TJX) | 2.0 | $92M | 1.8M | 50.56 | |
| McKesson Corporation (MCK) | 1.9 | $89M | 580k | 153.42 | |
| Centene Corporation (CNC) | 1.9 | $88M | 1.4M | 63.55 | |
| KBR (KBR) | 1.5 | $71M | 3.2M | 22.55 | |
| Amphenol Corp Cl A (APH) | 1.5 | $71M | 742k | 95.81 | |
| Norfolk Southern (NSC) | 1.5 | $70M | 401k | 175.57 | |
| Rockwell Automation (ROK) | 1.4 | $67M | 315k | 213.00 | |
| Laboratory Corp Amer Hldgs Com New (LH) | 1.4 | $66M | 398k | 166.11 | |
| Nike CL B (NKE) | 1.4 | $65M | 665k | 98.05 | |
| D.R. Horton (DHI) | 1.4 | $65M | 1.2M | 55.45 | |
| L3harris Technologies (LHX) | 1.4 | $64M | 376k | 169.67 | |
| Gap (GPS) | 1.4 | $63M | 5.0M | 12.62 | |
| Humana (HUM) | 1.3 | $62M | 159k | 387.75 | |
| Carvana Cl A (CVNA) | 1.3 | $60M | 495k | 120.20 | |
| Gfl Environmental Sub Vtg Shs (GFL) | 1.3 | $59M | 3.1M | 18.77 | |
| Hologic (HOLX) | 1.2 | $54M | 941k | 57.00 | |
| Anaplan | 1.1 | $51M | 1.1M | 45.31 | |
| Catalent (CTLT) | 1.1 | $50M | 676k | 73.30 | |
| Ross Stores (ROST) | 0.9 | $44M | 518k | 85.24 | |
| Quest Diagnostics Incorporated (DGX) | 0.9 | $41M | 358k | 113.96 | |
| CoStar (CSGP) | 0.7 | $33M | 46k | 710.68 | |
| Foley Trasimene Acquistn Cor Unit 99/99/9999 | 0.6 | $29M | 2.7M | 10.67 | |
| Social Cap Hedspia Hldg Co I Com Cl A | 0.6 | $28M | 2.5M | 11.18 | |
| Insmed Com Par $.01 (INSM) | 0.5 | $25M | 896k | 27.54 | |
| Tortoise Acquisition Corp Cl A | 0.5 | $24M | 890k | 27.44 | |
| Jaws Acquisition Corp Unit 99/99/9999 | 0.5 | $21M | 2.0M | 10.43 | |
| Bristol-myers Squibb Right 99/99/9999 | 0.4 | $17M | 4.8M | 3.58 | |
| Boston Scientific Corporation (BSX) | 0.3 | $16M | 455k | 35.11 | |
| Social Cap Hdosphia Hldg Shs Cl A | 0.3 | $14M | 1.2M | 11.75 | |
| Trebia Acquisition Corp Unit 99/99/9999 | 0.3 | $14M | 1.3M | 10.45 | |
| Selectquote Ord (SLQT) | 0.3 | $13M | 515k | 25.33 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.2 | $8.2M | 175k | 46.81 | |
| Draftkings Com Cl A | 0.2 | $7.0M | 212k | 33.26 | |
| Sutro Biopharma (STRO) | 0.2 | $7.0M | 903k | 7.76 | |
| Soleno Therapeutics Com New | 0.1 | $5.6M | 2.5M | 2.22 | |
| Marinus Pharmaceuticals | 0.1 | $5.1M | 2.0M | 2.54 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.1 | $4.3M | 100k | 42.56 | |
| Immunovant (IMVT) | 0.1 | $4.1M | 168k | 24.35 | |
| Coherus Biosciences (CHRS) | 0.1 | $3.2M | 181k | 17.86 | |
| Gs Acquisition Hldgs Corp Ii Unit 99/99/9999 | 0.1 | $3.2M | 300k | 10.51 | |
| Surface Oncology | 0.1 | $3.1M | 477k | 6.56 | |
| Pliant Therapeutics (PLRX) | 0.1 | $3.1M | 95k | 32.46 | |
| Kalvista Pharmaceuticals (KALV) | 0.1 | $3.0M | 247k | 12.10 | |
| Kezar Life Sciences (KZR) | 0.1 | $2.9M | 556k | 5.18 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $2.7M | 269k | 10.01 | |
| Chemocentryx Call Option | 0.1 | $2.6M | 45k | 57.53 | |
| Oric Pharmaceuticals (ORIC) | 0.1 | $2.6M | 76k | 33.73 | |
| Fate Therapeutics (FATE) | 0.1 | $2.6M | 75k | 34.31 | |
| Social Cap Hedspia Hldg Co I *w Exp 99/99/999 | 0.1 | $2.5M | 844k | 3.00 | |
| Aurinia Pharmaceuticals (AUPH) | 0.1 | $2.5M | 156k | 16.25 | |
| Bellus Health Com New | 0.1 | $2.5M | 241k | 10.29 | |
| Albireo Pharma | 0.0 | $2.1M | 81k | 26.49 | |
| Eiger Biopharmaceuticals | 0.0 | $1.9M | 199k | 9.60 | |
| Aduro Biotech | 0.0 | $1.9M | 803k | 2.31 | |
| Arya Sciences Acquistion Unit 06/09/2027 | 0.0 | $1.7M | 150k | 11.59 | |
| Turning Point Therapeutics I | 0.0 | $1.6M | 25k | 64.60 | |
| Social Cap Hdosphia Hldg *w Exp 99/99/999 | 0.0 | $1.5M | 405k | 3.62 | |
| Aeglea Biotherapeutics | 0.0 | $1.1M | 118k | 9.25 | |
| Homology Medicines | 0.0 | $1.1M | 71k | 15.19 | |
| Chiasma | 0.0 | $1.0M | 194k | 5.38 |
